103
Views
36
CrossRef citations to date
0
Altmetric
Original article

Modern modified ‘ultra’ Goeckerman therapy: A PASI assessment of a very effective therapy for psoriasis resistant to both prebiologic and biologic therapies

&
Pages 102-107 | Received 29 Apr 2004, Accepted 07 Feb 2005, Published online: 12 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Mio Nakamura & John Koo. (2020) Safety considerations with combination therapies for psoriasis. Expert Opinion on Drug Safety 19:4, pages 489-498.
Read now
Manuela L. Moscaliuc, Misha M. Heller, Eric S. Lee & John Koo. (2013) Goeckerman therapy: a very effective, yet often forgotten treatment for severe generalized psoriasis. Journal of Dermatological Treatment 24:1, pages 34-37.
Read now
Madison Dennis, Tina Bhutani, John Koo & Wilson Liao. (2013) Goeckerman therapy for the treatment of eczema: a practical guide and review of efficacy. Journal of Dermatological Treatment 24:1, pages 2-6.
Read now
Kristine L Busse, Ali Alikhan & Steven R Feldman. (2009) Optimizing topical therapy for psoriasis. Expert Review of Dermatology 4:4, pages 385-402.
Read now

Articles from other publishers (32)

Aslan YÜREKLİ, Mustafa TUNCA, Kadir KÜÇÜK, Ayşenur BOTSALİ & Ercan ÇALIŞKAN. (2022) Goeckerman therapy versus methotrexate for psoriasis: a study on military personnel. Journal of Health Sciences and Medicine 5:1, pages 297-300.
Crossref
Kristen M. Beck & John Koo. 2021. Advances in Psoriasis. Advances in Psoriasis 71 91 .
Jindra Šmejkalová, Lenka Borská, Květa Hamáková, Lenka Hodačová, Eva Čermáková & Zdeněk Fiala. (2020) Quality of life of patients with psoriasis. Central European Journal of Public Health 28:3, pages 219-225.
Crossref
Vidhatha Reddy, Shawn Thomas, Quinn Thibodeaux, Bridget Myers, Tina Bhutani & Wilson Liao. (2020) Psoriasis Vulgaris Successfully Treated with Goeckerman Treatment at Home: A Patient and Physician’s Experience. Dermatology and Therapy 10:3, pages 329-338.
Crossref
Mio Nakamura, Caleb Jeon & John Koo. 2018. Evidence-Based Psoriasis. Evidence-Based Psoriasis 113 128 .
J.-C. Beani. (2017) Fototerapia y fotoquimioterapia por ultravioletas. EMC - Dermatología 51:2, pages 1-17.
Crossref
John Koo & Mio NakamuraJohn Koo & Mio Nakamura. 2017. Clinical Cases in Phototherapy. Clinical Cases in Phototherapy 45 55 .
Dorothy L. Rodenbeck, Jonathan I. Silverberg & Nanette B. Silverberg. (2016) Phototherapy for atopic dermatitis. Clinics in Dermatology 34:5, pages 607-613.
Crossref
Tian Hao Zhu, Mio Nakamura, Benjamin Farahnik, Michael Abrouk, Rasnik K. Singh, Kristina M. Lee, Sarah Hulse, John Koo, Tina Bhutani & Wilson Liao. (2016) The Patient’s Guide to Psoriasis Treatment. Part 4: Goeckerman Therapy. Dermatology and Therapy 6:3, pages 333-339.
Crossref
Melissa Danesh, Catherine Nguyen, Kourosh Beroukhim & John Koo. (2015) Evolution of Topical Therapy in the Treatment of Psoriasis: A Review. Journal of Psoriasis and Psoriatic Arthritis 1:1a, pages 2-13.
Crossref
Clemens Painsi, Michael Patscheider, Martin Inzinger, Bernhard Lange-Asschenfeldt, Franz Quehenberger & Peter Wolf. (2015) Die Behandlung der Psoriasis mit klassischer, stationärer Dithranol-Therapie: eine retrospektive Patientenbefragung. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 13:11, pages 1156-1164.
Crossref
Clemens Painsi, Michael Patscheider, Martin Inzinger, Bernhard Lange-Asschenfeldt, Franz Quehenberger & Peter Wolf. (2015) Patient perspectives on treating psoriasis with classic inpatient dithranol therapy: a retrospective patient survey. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 13:11, pages 1156-1163.
Crossref
Tomas Toledo-Pastrana, María José García-Hernández, Ana María Carrizosa-Esquivel & Francisco Miguel Camacho-Martínez. (2015) Evaluation of 25 years of phototherapy for treating psoriasis at a teaching hospital in southern Spain. Anais Brasileiros de Dermatologia 90:4, pages 473-478.
Crossref
Tien V. Nguyen & John Y. M. Koo. 2014. Advances in Psoriasis. Advances in Psoriasis 91 110 .
Sarah Fitzmaurice, Tina Bhutani & John Koo. (2013) Goeckerman regimen for management of psoriasis refractory to biologic therapy: The University of California San Francisco experience. Journal of the American Academy of Dermatology 69:4, pages 648-649.
Crossref
Ethan C. Levin, Rishu Gupta & Kanade Shinkai. (2018) Duration of Remission of Topical Psoriasis Therapies. Psoriasis Forum 19a:1, pages 22-33.
Crossref
Steven R FeldmanKristine B ZitelliAli Alikhan. 2011. Current and Emerging Treatments for Psoriasis. Current and Emerging Treatments for Psoriasis 32 59 .
Matthew Matsunaga, Eric S. Lee, Misha M. Heller & John Koo. (2018) Care of Generalized Psoriasis in Elderly Patients beyond Topical Therapy: A Review and a Proposed Algorithm. Psoriasis Forum 17a:2, pages 105-116.
Crossref
Judith Hong, Joerg Buddenkotte, Timothy G. Berger & Martin Steinhoff. (2011) Management of Itch in Atopic Dermatitis. Seminars in Cutaneous Medicine and Surgery 30:2, pages 71-86.
Crossref
Tina Bhutani. (2018) Update on Combination Treatment with Acitretin for Generalized Psoriasis. Psoriasis Forum 16a:3, pages 37-42.
Crossref
Daniel Gold & Saad I. Almohizea. (2018) Topical Treatment of Mild to Moderate Psoriasis. Psoriasis Forum 16a:2, pages 17-25.
Crossref
Rebecca Penzer & Steven J. Ersser. 2010. Principles of Skin Care. Principles of Skin Care 119 149 .
Lenka Borska, Ctirad Andrys, Jan Krejsek, Kvetoslava Hamakova, Jan Kremlacek, Vladimir Palicka, Dianna Ranna & Zdenek Fiala. (2010) Genotoxic and apoptotic effects of Goeckerman therapy for psoriasis. International Journal of Dermatology 49:3, pages 289-294.
Crossref
Rebeca de Miguel & Rokea el-Azhary. (2009) Efficacy, safety, and cost of Goeckerman therapy compared with biologics in the treatment of moderate to severe psoriasis. International Journal of Dermatology 48:6, pages 653-658.
Crossref
Lenka Borska, Ctirad Andrys, Jan Krejsek, Kvetoslava Hamakova, Jan Kremlacek, Karel Ettler, Sajith Vellappally, Jacob Vimal & Zdenek Fiala. (2009) Genotoxic Hazard and Cellular Stress in Pediatric Patients Treated for Psoriasis with the Goeckerman Regimen. Pediatric Dermatology 26:1, pages 23-27.
Crossref
Mark R. Pittelkow & Joseph Genebriera. 2009. Pharmacology and Therapeutics. Pharmacology and Therapeutics 983 1005 .
Andrys Ctirad, Borska Lenka, Pohl David, Fiala Zdenek, Hamakova Kveta, Ettler Karel & Krejsek Jan. (2008) Goeckerman's therapy for psoriasis with special reference to serum pentraxin 3 level. International Journal of Dermatology 47:10, pages 1011-1014.
Crossref
Junling Zhang, David N. Adam, Elaine Stebbing, Judith Gerbrandt, Harvey Lui, Jerry Shapiro & Youwen Zhou. (2008) Efficacy of a Day-Care Program in the Treatment of Psoriasis. Journal of Cutaneous Medicine and Surgery 12:5, pages 211-216.
Crossref
Rahat S. Azfar & Abby S. Van Voorhees. 2008. Treatment of Psoriasis. Treatment of Psoriasis 71 101 .
Paru R. Chaudhari, Dana K. Stern & Mark G. Lebwohl. 2008. Treatment of Psoriasis. Treatment of Psoriasis 57 70 .
C. Andrys, L. Borska, D. Pohl, Z. Fiala, K. Hamakova & J. Krejsek. (2007) Angiogenic activity in patients with psoriasis is significantly decreased by Goeckerman’s therapy. Archives of Dermatological Research 298:10, pages 479-483.
Crossref
Zdenek Fiala, Lenka Borska, Anna Pastorkova, Jan Kremlacek, Milena Cerna, Jindra Smejkalova & Kvetoslava Hamakova. (2006) Genotoxic effect of Goeckerman regimen of psoriasis. Archives of Dermatological Research 298:5, pages 243-251.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.